Adamas Pharmaceuticals, Inc.
10 clinical trials · Sponsor
◉ Watch Adamas Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment (NCT03567057) | Adamas Pharmaceuticals, Inc. | 2018-07-18 |
| Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment (NCT03436199) | Adamas Pharmaceuticals, Inc. | 2018-03-29 |
Track Adamas Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.